期刊文献+

生物荧光氧化硅纳米颗粒的研制与应用 被引量:6

Synthesis and Applications of Florescence-Doped Silica Nanoparticles
下载PDF
导出
摘要 运用OP-10(壬基酚聚氧乙烯醚)/环己烷/氨水微乳液自组装体系合成了罗丹明B嵌入的荧光氧化硅纳米颗粒.通过电镜检测、光谱分析以及荧光猝灭试验研究了荧光颗粒的特性.将荧光纳米颗粒与培养细胞共培育后,通过激光扫描共聚焦显微镜和流式细胞仪研究了不同时间点细胞内荧光信号和荧光强度.结果表明,合成的荧光氧化硅纳米颗粒粒径小(约20nm),分布均匀,形态规则,表面光滑圆润,发光性质稳定.它可被体外培养细胞有效摄入,并可在培养细胞中检测到较强的荧光信号和较高的荧光强度.这提示生物荧光氧化硅纳米颗粒在细胞生物学、超微化学与免疫检测等领域将具有重要应用前景. The fluorescence-doped Silica nanoparticles (FDS-NP) were synthesized in a microemulsion system of polyoxyethylene nonylphenyl ether (OP-10)/ cyclohexane/ammonium hydroxide. To elucidate the character of FDS-NP, techniques of electron microscopy, analysis of spectrum and collisional quenching of fluorescence were used. In order to study the fluorescent signal and intensity of FDS-NP in the cultured cells, laser-scanning confocal microscope and the analysis of flow cytometry were utilized. The results showed that the size of FDS-NP was very small (about 20 nm), the distribution was narrow, the shape was circular and lubricity, and the fluorescence was photostable. Cultured cells could efficiently uptake FDS-NP, and yield high fluorescent signal and intensity. All these indicated that FDS-NP is an important nanoparticulate biomarker, and is applicable to many areas of modem biochemical analysis, such as ultrasensitive detection, immunoassys, as well as cellular biology.
出处 《物理化学学报》 SCIE CAS CSCD 北大核心 2003年第4期311-314,共4页 Acta Physico-Chimica Sinica
基金 教育部科学技术研究重点项目(01130) 国家自然科学基金(30171056) 教育部重大项目基金(2000-156) 湖南省自然科学基金(01JJY2020)资助项目~~
关键词 氧化硅 纳米颗粒 纳米生物标志物 罗丹明B 半导体纳米晶 壬基酚聚氧乙烯醚 环己烷 自组装 细胞生物学 超微化学 免疫检测 nanoparticulate biomarker silica nanoparticles rhodamine B fluorescent nanoparticles synthesis and applications
  • 相关文献

参考文献11

  • 1[1]Lacoste,T.D.;Michalet,X.;Pinaud,F.;Chemla,D.S.; Alivisatos,A.P.;Weiss,S.Proc. Natl. Acad. Sci.,USA,2000,97(17):9461
  • 2[2]Uppenbrink,J.;Clery,D.Science,1999;283:1667
  • 3[3]Moerner,W.E.;Orrit,M.Science,1999;283:1670
  • 4[4]Weiss,S.Science,1999,283:1676
  • 5[5]Bruchez,M.Jr.;Moronne,M.;Gin,P.;Weiss,S.;Alivisatos, A.P.Science,1998,281:2013
  • 6[6]Adler,J.;Jayan,A.;Melia,C.D.J.Pharm.Sci.,1999,88(3): 371
  • 7[7]Santra,S.;Zhang,P.;Wang,K.;Tapec,R.;Tan,W.Anal. Chem.,2001,73(20):4988
  • 8[9]Zhu,S.G.;Lu,H.B.;Xiang,J.J.;Tang,K.;Zhang,B.C.; Zhou,M.;Tan,C.;Li,G.Y.China Sci.Bull.,2002;47(8):654
  • 9[10]Lambert,G.;Fattal,E.;Pinto-Alphandary,H.;Gulik,A.; Couvreur,P.Pharm. Res.,2000,17:707
  • 10[11]Watt,R.M.;Voss,E.W.Jr.J.Biol. Chem.,1979;254(5): 1684

同被引文献234

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部